author-photo

Niels Viggo Jensen

Odense University Hospital

31

Papers

322

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

Real-world Treatment Patterns and Overall Survival in Locally Advanced and Metastatic Urothelial Tract Cancer Patients Treated with Chemotherapy in Denmark in the Preimmunotherapy Era: A Nationwide, Population-based Study

2021
Show All
- Source
- Cite
- Save
Citations (2)
Real-World Study of Treatment with Pembrolizumab Among Patients with Advanced Urothelial Tract Cancer in Denmark

2021
Show All
- Source
- Cite
- Save
Citations (0)
Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (11)
A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1

2018 Acta Oncologica
Show All
- Source
- Cite
- Save
Citations (9)
Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) versus everolimus (eve) in patients with advanced renal cell carcinoma (RCC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
A randomized phase II trial of interleukin-2/interferon-α plus bevacizumab versus interleukin-2/interferon-α in metastatic renal cell carcinoma (mRCC): Results from the Danish Renal Cancer Group (DARENCA) study 1.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Trends in kidney cancer among the elderly in Denmark, 1980–2012

2016 Acta Oncologica
Show All
- Source
- Cite
- Save
Citations (12)
Trends in cancer of the urinary bladder and urinary tract in elderly in Denmark, 2008–2012

2016 Acta Oncologica
Show All
- Source
- Cite
- Save
Citations (6)
Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis.

2016 Oncology Letters
Show All
- Source
- Cite
- Save
Citations (8)
A five-factor biomarker profile obtained week 4-12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2

2016 Acta Oncologica
Show All
- Source
- Cite
- Save
Citations (13)